Precise Biometrics announces outcome of exercise period for warrants of series 2026 (TO2)
Precise Biometrics announces outcome of exercise period for warrants of series 2026 (TO2)
Precise Biometrics AB (publ) (the “Company”) today announces the outcome of the exercise period for warrants of series 2026 (TO2) (the “Warrants”). In total, 1,151,234,990 Warrants were exercised and the Company will thereby receive approximately SEK 2.6 million before issue costs.
Of the total 1,855,541,003 issued Warrants, 1,151,234,990 Warrants have been exercised for subscription of 5,456,090 new shares in the Company at a subscription price of SEK 0.47 per share, corresponding to an exercise rate of approximately 62 percent. Through the exercise of the Warrants, the Company will receive approximately SEK 2.6 million before issue costs.
Through the exercise of the Warrants, the share capital increases by SEK 1,636,827, from SEK 80,606,288.70 to SEK 82,243,115.70, through a new issue of 5,456,090 new ordinary shares, which means that the total number of shares increases from 268,687,629 shares to 274,143,719 shares, of which 273,058,719 ordinary shares and 1,085,000 C-shares[1].
[1] Outstanding C shares in Precise Biometrics have been issued under incentive programmes and are held by the Company.